Similar articles for PMID: 22253920

Year	Number of Results
2002	1
2006	1
2007	3
2008	1
2009	3
2010	5
2011	8
2012	9
2013	9
2014	8
2015	13
2016	16
2017	12
2018	11
2019	14
2020	4
2021	5
2022	7
2023	4
2024	0

1

p63 expression defines a lethal subset of muscle-invasive bladder cancers.

Choi W, Shah JB, Tran M, Svatek R, Marquis L, Lee IL, Yu D, Adam L, Wen S, Shen Y, Dinney C, McConkey DJ, Siefker-Radtke A. Choi W, et al. PLoS One. 2012;7(1):e30206. doi: 10.1371/journal.pone.0030206. Epub 2012 Jan 10. PLoS One. 2012. PMID: 22253920 Free PMC article.

2

The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.

Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B, Dinney C, Barton M, McConkey DJ. Tran MN, et al. J Biol Chem. 2013 Feb 1;288(5):3275-88. doi: 10.1074/jbc.M112.408104. Epub 2012 Dec 13. J Biol Chem. 2013. PMID: 23239884 Free PMC article.

3

Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.

Wu K, Zeng J, Zhou J, Fan J, Chen Y, Wang Z, Zhang T, Wang X, He D. Wu K, et al. Urol Oncol. 2013 Nov;31(8):1751-60. doi: 10.1016/j.urolonc.2012.02.001. Epub 2012 Mar 14. Urol Oncol. 2013. PMID: 22421353

4

Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.

Singh R, Ansari JA, Maurya N, Mandhani A, Agrawal V, Garg M. Singh R, et al. Clin Genitourin Cancer. 2017 Apr;15(2):e187-e197. doi: 10.1016/j.clgc.2016.07.021. Epub 2016 Aug 9. Clin Genitourin Cancer. 2017. PMID: 27601277

5

Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients.

Singh R, Singh UP, Agrawal V, Garg M. Singh R, et al. Mol Biol Rep. 2022 Aug;49(8):7541-7556. doi: 10.1007/s11033-022-07563-2. Epub 2022 May 20. Mol Biol Rep. 2022. PMID: 35593896

6

Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.

Ottley EC, Pell R, Brazier B, Hollidge J, Kartsonaki C, Browning L, O'Neill E, Kiltie AE. Ottley EC, et al. J Pathol Clin Res. 2020 Oct;6(4):238-251. doi: 10.1002/cjp2.167. Epub 2020 May 6. J Pathol Clin Res. 2020. PMID: 32374509 Free PMC article.

7

CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.

Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL. Liang W, et al. Urol Oncol. 2014 Aug;32(6):855-63. doi: 10.1016/j.urolonc.2014.01.005. Epub 2014 Jun 23. Urol Oncol. 2014. PMID: 24968949

8

Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer.

Zhao J, Dong D, Sun L, Zhang G, Sun L. Zhao J, et al. Int Braz J Urol. 2014 Mar-Apr;40(2):179-89. doi: 10.1590/S1677-5538.IBJU.2014.02.07. Int Braz J Urol. 2014. PMID: 24856504 Free article.

9

ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion.

Dang TT, Westcott JM, Maine EA, Kanchwala M, Xing C, Pearson GW. Dang TT, et al. Oncotarget. 2016 May 10;7(19):28592-611. doi: 10.18632/oncotarget.8696. Oncotarget. 2016. PMID: 27081041 Free PMC article.

10

Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer.

Wang L, Zhao J, Yang C, Kuang R, Kazobinka G, Pang Z, Hou T. Wang L, et al. Cell Physiol Biochem. 2018;48(6):2364-2373. doi: 10.1159/000492652. Epub 2018 Aug 16. Cell Physiol Biochem. 2018. PMID: 30114689 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

116 results

Results by year